Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
acromegaly
Biotech
Crinetics pads case for oral hormone disorder drug
Crinetics' oral med regulated levels of a hormone associated with acromegaly in a phase 3 test, setting up a regulatory submission in the second half.
Annalee Armstrong
Mar 19, 2024 9:30am
Crinetics soars as oral rare disease drug meets standard of care
Sep 11, 2023 7:16am
Ionis' midphase misses send rare disease prospects to the abyss
May 4, 2023 10:25am
Midatech ‘urgently’ needs investor as cash reserves dwindle
Jan 25, 2019 10:45am
Endocrine specialist Crinetics tees up for $86M IPO
Jun 25, 2018 8:15am
Crinetics raises $63.5M for oral acromegaly therapy
Mar 14, 2018 9:10am